The key to successful healthcare market research is high-quality respondent participation, especially among physicians. For Reckner Healthcare, that means finding the right person, making sure they will give thoughtful, high-quality responses and complete your research. It’s equally as important to keep them engaged so they are willing and want to participate in future projects. This also means we are continually growing our panels, so we have enough of the right people when our clients need them. That’s why we implemented Respondent First™.
Respondent First™ began as a very deliberate, company-wide strategy to make Reckner Healthcare the go-to supplier of physician access in the United States. Since its introduction:
- Our physician panel grew 4% in 2022.
- Reckner’s ability to fill quotas by specialty has also improved and our clients have taken notice. In 2022, 98% more in the Radiation and Oncology sector, nearly 62% more with Ophthalmologists, 64% more with Rheumatologists, 57% more in the Allergy and Immunology field, and 28% more with Nephrology.
- We have also grown in our ability to reach specialty nurses, nurse practitioners, and physician assistants, whose sphere of influence in healthcare and importance to market research has dramatically risen over the last two years, leading to a 30% increase in studies that include these professionals.
- Email deliverability is excellent, with Sender Score consistently rating us 99/100 and Google rating us with zero delivery errors.
Our HCP panelists have responded very positively to the policies of Respondent First™, as illustrated by this representative testimonial from one of our panel physicians: “I have participated in many Reckner surveys over the years, and this sounds great. Thank you for respecting my time. I look forward to seeing new survey opportunities.”
We introduced Respondent First™ a few years ago to formalize our approach to treating our panel members respectfully and professionally. This became Reckner’s philosophy for running our business, encompassing all aspects of managing our business and ensuring our research community’s long-term health. We believe that by taking care of our panelists today, they will continue to participate in and take care of your studies in the future.